Shanting Liao

765 total citations · 1 hit paper
18 papers, 586 citations indexed

About

Shanting Liao is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Shanting Liao has authored 18 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 5 papers in Pharmacology. Recurrent topics in Shanting Liao's work include Metabolomics and Mass Spectrometry Studies (8 papers), Traditional Chinese Medicine Analysis (5 papers) and Berberine and alkaloids research (3 papers). Shanting Liao is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (8 papers), Traditional Chinese Medicine Analysis (5 papers) and Berberine and alkaloids research (3 papers). Shanting Liao collaborates with scholars based in China and United States. Shanting Liao's co-authors include Junsong Wang, Ding‐Qiao Xu, Chao Han, Lingyi Kong, Ming‐Hua Yang, Ling‐Yi Kong, Lingyi Kong, Yan Lv, Pei Li and Yan Lv and has published in prestigious journals such as Nature Communications, Biosensors and Bioelectronics and RSC Advances.

In The Last Decade

Shanting Liao

18 papers receiving 586 citations

Hit Papers

4-Octyl itaconate inhibits aerobic glycolysis by targetin... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanting Liao China 12 326 187 79 65 60 18 586
Changqing Zheng China 14 327 1.0× 114 0.6× 88 1.1× 73 1.1× 79 1.3× 29 695
Xuefeng Wu China 14 280 0.9× 206 1.1× 62 0.8× 46 0.7× 49 0.8× 24 541
Zibin Lu China 15 325 1.0× 117 0.6× 87 1.1× 87 1.3× 85 1.4× 35 603
Seong‐Man Kim South Korea 12 232 0.7× 164 0.9× 103 1.3× 49 0.8× 42 0.7× 28 610
Chu-Tian Mai China 11 354 1.1× 169 0.9× 92 1.2× 38 0.6× 99 1.6× 15 628
Qun Du China 14 349 1.1× 73 0.4× 53 0.7× 38 0.6× 43 0.7× 23 543
Lei Shen China 15 326 1.0× 196 1.0× 54 0.7× 39 0.6× 90 1.5× 30 707
Le Shi China 16 377 1.2× 134 0.7× 38 0.5× 68 1.0× 141 2.4× 56 848
Qun Zhao China 16 253 0.8× 75 0.4× 77 1.0× 53 0.8× 45 0.8× 50 701
Anne B. Hofseth United States 14 384 1.2× 105 0.6× 69 0.9× 79 1.2× 120 2.0× 16 777

Countries citing papers authored by Shanting Liao

Since Specialization
Citations

This map shows the geographic impact of Shanting Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanting Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanting Liao more than expected).

Fields of papers citing papers by Shanting Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanting Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanting Liao. The network helps show where Shanting Liao may publish in the future.

Co-authorship network of co-authors of Shanting Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Shanting Liao. A scholar is included among the top collaborators of Shanting Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanting Liao. Shanting Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Wenjie, Steven H. Lin, Qin Zhang, et al.. (2024). Bortezomib induces cell apoptosis and increases the efficacy of αPD-1 in BCR::ABL T315I mutation CML by targeting UBE2Q1. International Immunopharmacology. 143(Pt 2). 113311–113311. 1 indexed citations
2.
Hu, Huiting, et al.. (2024). Dimethyl fumarate covalently modifies Cys673 of NLRP3 to exert anti-inflammatory effects. iScience. 27(4). 109544–109544. 1 indexed citations
3.
Xu, Xiao, et al.. (2024). Enhanced Fe(ii)-artemisinin-mediated chemodynamic therapy with efficient Fe(iii)/Fe(ii) conversion circulation for cancer treatment. Biomaterials Science. 12(22). 5856–5869. 2 indexed citations
4.
Tang, Pengfei, Shanting Liao, Shanshan Wei, et al.. (2021). Shizukaol A exerts anti-inflammatory effect by regulating HMGB1/Nrf2/HO-1 pathway. Phytomedicine. 82. 153472–153472. 32 indexed citations
5.
Han, Chao, Xiao Xu, Can Zhang, et al.. (2020). Cytochrome c light-up graphene oxide nanosensor for the targeted self-monitoring of mitochondria-mediated tumor cell death. Biosensors and Bioelectronics. 173. 112791–112791. 19 indexed citations
6.
Xu, Ding‐Qiao, Shanting Liao, Yan Lv, Junsong Wang, & Ling‐Yi Kong. (2020). NMR-based metabolomics approach reveals effects of antioxidant nutrients in sepsis-induced changes in rat liver injury. The Journal of Nutritional Biochemistry. 85. 108440–108440. 6 indexed citations
7.
Wang, Junsong, Shanting Liao, Yan Lv, et al.. (2019). 1H NMR-Based Metabolomics Reveals Refined-Huang-Lian-Jie-Du-Decoction (BBG) as a Potential Ischemic Stroke Treatment Drug With Efficacy and a Favorable Therapeutic Window. Frontiers in Pharmacology. 10. 337–337. 25 indexed citations
8.
Liao, Shanting, et al.. (2019). 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nature Communications. 10(1). 5091–5091. 314 indexed citations breakdown →
9.
Xu, Ding‐Qiao, Shanting Liao, Pei Li, et al.. (2018). Metabolomics Coupled with Transcriptomics Approach Deciphering Age Relevance in Sepsis. Aging and Disease. 10(4). 854–854. 17 indexed citations
10.
Li, Pei, Shanting Liao, Junsong Wang, et al.. (2018). Pharmacokinetic and NMR metabolomics approach to evaluate therapeutic effect of berberine and Coptidis Rhizoma for sepsis. Chinese Herbal Medicines. 11(1). 28–38. 1 indexed citations
11.
Lv, Yan, Junsong Wang, Ding‐Qiao Xu, et al.. (2017). Comparative study of single/combination use of Huang-Lian-Jie-Du decoction and berberine on their protection on sepsis induced acute liver injury by NMR metabolic profiling. Journal of Pharmaceutical and Biomedical Analysis. 145. 794–804. 23 indexed citations
12.
Zhang, Qian, Junsong Wang, Shanting Liao, et al.. (2017). Optimization of Huang-Lian-Jie-Du-Decoction for Ischemic Stroke Treatment and Mechanistic Study by Metabolomic Profiling and Network Analysis. Frontiers in Pharmacology. 8. 165–165. 26 indexed citations
13.
Liao, Shanting, Junsong Wang, Ding‐Qiao Xu, et al.. (2016). NMR metabolic profiling of lipopolysaccharide-induced mice sepsis and the treatment effects of berberine. RSC Advances. 6(53). 47474–47485. 13 indexed citations
14.
Liao, Shanting, Pei Li, Junsong Wang, et al.. (2016). Protection of baicalin against lipopolysaccharide induced liver and kidney injuries based on 1H NMR metabolomic profiling. Toxicology Research. 5(4). 1148–1159. 20 indexed citations
15.
Liao, Shanting, Pei Li, Junsong Wang, et al.. (2016). Huang-Lian-Jie-Du decoction treated sepsis via regulating ERK and SRC/STAT3 pathways and ameliorating metabolic status. RSC Advances. 6(92). 89855–89866. 8 indexed citations
16.
Li, Pei, Shanting Liao, Junsong Wang, et al.. (2016). Protection by Huang‐Lian‐Jie‐Du decoction and its constituent herbs of lipopolysaccharide‐induced acute kidney injury. FEBS Open Bio. 7(2). 221–236. 27 indexed citations
17.
Zhang, Qian, Junsong Wang, Chao Zhang, et al.. (2016). The components of Huang-Lian-Jie-Du-Decoction act synergistically to exert protective effects in a rat ischemic stroke model. Oncotarget. 7(49). 80872–80887. 37 indexed citations
18.
Wei, Dandan, Shanting Liao, Junsong Wang, Ming‐Hua Yang, & Ling‐Yi Kong. (2015). Cholestatic liver injury model of bile duct ligation and the protection of Huang-Lian-Jie-Du decoction by NMR metabolomic profiling. RSC Advances. 5(81). 66200–66211. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026